Viela Bio (VIE) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free VIE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFcRn Inhibitor Market is Predicted to Grow Rapidly During the Study Period (2020–2034) | DelveInsightfinance.yahoo.com - April 16 at 2:54 PMArriVent Wows Investors With Promising China-Developed Lung Cancer Treatmentbenzinga.com - January 29 at 2:49 PMArriVent Biopharma issues upsized $175M IPO, becomes region's first life sciences firm to go public in 2024bizjournals.com - January 27 at 3:29 AMArriVent Biopharma Seeks $100 Million IPO For Lung Cancer Drugseekingalpha.com - January 9 at 2:41 PMArriVent BioPharma Files For IPOmarketwatch.com - January 5 at 8:54 PMMyasthenia Gravis Treatment Market Size, Share & Growth Analysis, [2028] | With CAGR of 7.5%finance.yahoo.com - December 6 at 12:06 PMGlobal CD19 Antibody Market and Clinical Pipeline Outlook and Competitive Landscape: Insight on 30 Key Playersbenzinga.com - November 17 at 2:50 PMGlobal CD19 Antibody Market Projected to Exceed $10 Billion by 2028, Driven by Promising Pipeline of Therapiesuk.finance.yahoo.com - November 9 at 9:52 AMGlobal CD19 Antibody Market Set to Surpass $10 Billion by 2028: A Revolutionary Era in Immunotherapyfinance.yahoo.com - November 3 at 10:43 AMAmgen’s layoffs won’t affect Horizon Therapeutics’ Rockville footprint — for nowbizjournals.com - October 25 at 7:50 PMEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officerfinanznachrichten.de - October 23 at 10:13 AMArgenx's 28% Surge & Promising Product Propel Investor Confidence (VIE)marketbeat.com - September 25 at 7:10 AMInside 'Elon Musk': Wild details from revealing Walter Isaacson biographyusatoday.com - September 20 at 7:38 PMI’m an AI influencer: Followers crave my sexy snaps — but I don’t existnypost.com - July 26 at 4:51 PM2023 Cutaneous Lupus Erythematosus (CLE) Treatment Market: Latest Technology Innovations and Comprehensive Growth Insights by 2031marketwatch.com - May 8 at 11:06 PMCutaneous Lupus Erythematosus (CLE) Treatment Market: Opportunities for Industry Expansion in 2030marketwatch.com - May 5 at 8:00 PM8-K: Horizon Therapeutics Public Ltd Comarketwatch.com - May 5 at 9:59 AMArriVent Biopharma raises $155M in one of largest local funding rounds of 2023bizjournals.com - March 27 at 3:16 PMCutaneous Lupus Erythematosus (CLE) Treatment Market Application, Product, Sales and Forecast 2023-2028marketwatch.com - March 9 at 9:39 AMExploring the Challenges and Opportunities in the Cutaneous Lupus Erythematosus (CLE) Treatment Market (2023-2028)marketwatch.com - February 10 at 7:39 AMNeuromyelitis Optica Spectrum Disorder (NMOSD) Market is Set to Grow in forecast period 2029marketwatch.com - January 20 at 9:23 AMWith Horizon acquisition, Amgen would enter Montgomery County for the first time. Here’s what we know.bizjournals.com - December 13 at 5:07 PMHorizon Therapeutics spells out vision for Rockville R&D hubbizjournals.com - December 1 at 7:34 PMLife sciences firm MilliporeSigma doubling down on MoCo with $286M investmentbizjournals.com - November 16 at 7:41 PMSBI Holdings, Inc. (SBHGF) Q2 2023 Earnings Call Transcriptseekingalpha.com - November 15 at 6:13 PMWhy Horizon Therapeutics' Shares Rose 11.32% on Wednesdaymsn.com - November 2 at 11:36 PMCutaneous Lupus Erythematosus (CLE) Treatment Market Size, Sales, CAGR And Competition Data from 2022 To 2028marketwatch.com - October 21 at 7:18 PMAlpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Resultsnz.finance.yahoo.com - August 11 at 6:59 PMViela Bio, Inc. Newsthestreet.com - August 2 at 11:21 PMHorizon Therapeutics: Buy The Dip For Slightly Risky, Catalyst Driven Growthseekingalpha.com - July 31 at 9:08 AMAlpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directorsapnews.com - July 19 at 9:57 AMCANbridge Appoints Industry Leader Edward Hu to the Boardnz.finance.yahoo.com - July 5 at 9:23 AMMyasthenia Gravis Treatment Market Size [2022-2029]: $2.03 Billion by 2028 at CAGR of 7.5%ca.finance.yahoo.com - May 26 at 9:04 AMHorizon: For Those Who Dareseekingalpha.com - May 9 at 2:19 PMImprove Your Portfolio’s Health By Investing In Health Care Stocksforbes.com - April 14 at 12:17 AMHorizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidancebenzinga.com - March 1 at 6:42 PMMyasthenia Gravis Treatment Market Size [2022-2028] worth USD 2.03 billion | Exhibit a CAGR of 7.5%finance.yahoo.com - February 28 at 9:40 AMHansoh Pharmaceutical Group Co Ltd (3692)investing.com - February 26 at 8:40 PMArriVent Biopharma hits key milestones, triggers additional $69M investmentbizjournals.com - February 15 at 7:17 PMSystemic Lupus Erythematosus Pipeline Insights | Research Report 2022 by DelveInsightfinance.yahoo.com - February 9 at 5:52 PMHorizon Therapeutics signs lease for big expansion in Montgomery Countybizjournals.com - January 7 at 10:23 AMDublin biotech signs lease for big expansion in Marylandbizjournals.com - January 7 at 10:23 AMViela Bio Inc (VIE)investing.com - January 5 at 4:18 AMPolymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes DelveInsightfinance.yahoo.com - December 8 at 3:12 PMRecord Funding Invested in Montgomery County, Maryland Companies in 2021 Q1-Q3finance.yahoo.com - November 2 at 10:04 PMNeuromyelitis Optica Drug Market Report 2021 Offered by Practical Features, Leading Vendors, End Uses, Product Types and Revenue by 2026marketwatch.com - September 27 at 3:41 PMVC Daily: Biotechs Seek New Skill Set From Scientists Entering Fieldmorningstar.com - September 23 at 2:35 PMBe Bio Appoints Mitchell Chan as Chief Financial Officer & Head of Corporate Strategyfinance.yahoo.com - September 22 at 12:24 AMIP Hires: Aeglea BioTherapeutics, Copyright Claims Boardlaw360.com - July 23 at 11:55 PM Get Viela Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for VIE and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy VIE Media Mentions By Week VIE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIE News Sentiment▼0.000.41▲Average Medical News Sentiment VIE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIE Articles This Week▼00▲VIE Articles Average Week Get Viela Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for VIE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HUTCHMED News Arrowhead Pharmaceuticals News ACADIA Pharmaceuticals News MoonLake Immunotherapeutics News IDEAYA Biosciences News Amicus Therapeutics News MorphoSys News Xenon Pharmaceuticals News Indivior News Bausch Health Companies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viela Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
